ViCentra
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $78.3Mattributed |
|---|---|
| Latest round | series-d+, $78.3M, 2025-09-01attributed |
| Founded | 2009 |
| Headquarters | Utrecht |
| Industry | healthtech |
| Stage | series-b+ |
| Website | hellokaleido.com |
Kaleido is a 19-gram tubed-or-patch insulin pump that runs as a hybrid closed loop with the Diabeloop DBLG1 algorithm and Dexcom G6 CGM. It targets adults with type 1 diabetes in the Netherlands and Germany. Custom colors, swimmable casing, a four-year warranty, and reusable parts position the pump as a lifestyle accessory rather than medical hardware.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-01 | series-d+ | $78.3M | undisclosed |
Detected tech stack
Cloudflare, WordPress, Astra 4.12.3, Yoast SEO 27.6, Kinsta, Google Analytics, Google Tag Manager, Site Kit 1.179.0, jQuery Migrate 3.4.1, jsDelivr, Elementor 4.0.9, PHP
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series D+, $78.3M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $78.3M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | hellokaleido.com, read 2026-05-07 |
| Description | self-reported | hellokaleido.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.